Somewhere between the ache of a stubborn stomach and the fear of what it might mean, a long-familiar medical question is being reshaped. English health officials are weighing whether a small swallowed capsule on a thread, drawn back up in minutes, should replace some waits for hospital scans. Its promise is modest but real: earlier, gentler sight of changes in the gullet lining that, for most people, will never become cancer, yet which can quietly raise the stakes over time. The guidance remains a draft, and the final word arrives in the new year.
Cancer 'Sponge on a String' Tests May Reach More Patients With Persistent Indigestion
A capsule on a thread, a few minutes, and no hospital visit
So what exactly is changing here? The test already exists.
It does, and some areas already offer it through pilots. The draft guidance would let it be offered across England, to some people with bad, persistent indigestion, and it can be done in a GP surgery in minutes.
Why does that matter for cancer specifically?
Reflux can come with Barrett's oesophagus, where cells in the gullet lining change. That raises cancer risk over the long term. An estimated one to two in 100 adults have it.
Worth saying most of those people won't develop cancer. The number is an estimate, and the article doesn't say how many are currently undiagnosed.
And the pressure on endoscopy is part of the story?
Yes. Demand is high, so some people with Barrett's aren't checked as often as recommended. A simpler first check could ease that.
That's the hope, but it's stated as a possibility. Nothing here shows yet how much endoscopy demand would fall.
What about the claim that thousands have benefited?
That comes from Prof Peter Johnson of NHS England, describing the pilots. It's his statement, not a published evaluation in this piece.
Right. And the caveat matters: no test catches everything, so an all-clear sponge result still means long-term monitoring. Also, these are draft guidelines. Final recommendations come in the new year.
The Pulse
- A common, nagging symptom of persistent indigestion now pushes against a crowded endoscopy system where waiting lists slow the checks people need.
- Draft NICE guidance proposes a minutes-long sponge test in GP surgeries, a shift that would move screening out of the hospital and into everyday primary care.
- Pilots already running across parts of England have helped thousands, and officials hope the method will free resources to catch cancers earlier.
- Because no test catches every case, the reassurance of a clear result comes with an ongoing duty of long-term monitoring.
- The final decision lands in the new year, determining whether the sponge becomes a standard option for patients across the country.
Somewhere between the ache of a stubborn stomach and the fear of what it might mean, a long-familiar medical question is being reshaped. English health officials are weighing whether a small swallowed capsule on a thread, drawn back up in minutes, should replace some waits for hospital scans. Its promise is modest but real: earlier, gentler sight of changes in the gullet lining that, for most people, will never become cancer, yet which can quietly raise the stakes over time. The guidance remains a draft, and the final word arrives in the new year.
A patient with indigestion that will not go away may soon be offered something far simpler than a hospital visit. A small capsule on a thread is swallowed at the GP surgery. Once it reaches the stomach, it releases a tiny sponge, which is gently drawn back up through the mouth, gathering cells from the lining of the gullet along the way. The whole thing takes minutes. Endoscopy, with its camera and hospital appointment, remains the usual route.
The proposal, set out in draft guidance from the National Institute for Health and Care Excellence, would offer the test to some people with severe, lasting reflux or indigestion. It is already in use in pilot schemes, and officials say thousands have benefited. The main concern is Barrett's oesophagus, a change in the gullet lining that can follow long-term acid reflux. Around one or two adults in every hundred have it, and most never develop cancer. Yet strained endoscopy services mean some are not checked as often as they should be.
NICE hopes the sponge will give patients peace of mind and point the most urgent cases toward further care. It is also honest about its limits: no test finds everything, so a clear result still calls for ongoing watchfulness. The final recommendations are due in the new year.
A patient who has lived with bad, persistent indigestion could soon be asked to swallow a small capsule on a thread at their local GP surgery, rather than waiting for a hospital appointment. That is the change proposed in new draft guidelines for the NHS in England, which recommend offering a quick "sponge in the gullet" test to some people with severe and lasting indigestion, as a check for oesophageal cancer.
The test works in a few simple steps. The patient swallows a dissolving capsule attached to a thread. Once it reaches the stomach, the capsule releases a tiny sponge. The doctor then gently pulls the thread, drawing the sponge back up and out through the mouth, and it collects cells from the lining of the gullet on the way. Those cells are then analysed. The whole procedure can be done in minutes, and it can take place in a GP surgery. Endoscopy, the usual alternative, uses a small camera to look inside the body and is done in hospital.
The tests are not new to England. They are already offered in some places, and Prof Peter Johnson, national clinical director for cancer at NHS England, said thousands of people have benefited through pilots the health service has been running. The draft guidance from the National Institute for Health and Care Excellence (NICE) raises the prospect of offering them across the country.
The condition at the centre of this is Barrett's oesophagus, in which cells in the gullet lining have started to change. It can occur alongside heartburn or acid reflux, and over the long term it raises the risk of cancer. An estimated one to two adults in every 100 have it. Most will not go on to develop cancer. But demand for NHS endoscopy is high, and as a result some people with the condition are not being checked as often as recommended.
NICE says the sponge tests could give more patients peace of mind. Prof Jonathan Benger, its chief executive, described them as a quick and less invasive way to spot concerning changes, helping to identify who should go on to have further tests and treatment. Prof Johnson said that many people have acid reflux, and that an easier way to check for changes in the oesophageal lining could make a real difference to patients. He added that it could reduce the need for more complicated endoscopy tests and help the NHS free up resources to find cancers at an earlier stage.
NICE is clear about the limits, however. No diagnostic test, endoscopy included, identifies every case. People who get an all-clear result from a sponge test should still be monitored in the long term. The tests can help detect both oesophageal cancer and Barrett's oesophagus in people with reflux disease.
Reflux itself is common. It causes heartburn, a burning sensation in the middle of the chest, along with an unpleasant sour taste in the mouth from stomach acid. Over time the acid can damage the lining of the oesophagus. A lax or weakened sphincter at the bottom of the food pipe, where it meets the stomach, can be part of the problem, letting digestive juices seep upward. Being overweight, smoking and drinking alcohol can all increase the risk of reflux.
The guidance is still a draft. NICE will make its final recommendations in the new year, and that decision will determine whether the sponge test becomes a standard option for patients across England.
Notable Quotes
Sponge tests offer a quick and less invasive way to detect concerning changes, helping identify people who should have further tests and treatment.— Prof Jonathan Benger, chief executive of NICE
Thousands have already benefited from the test through pilots, and an easier check can reduce the need for more complicated endoscopy tests.— Prof Peter Johnson, national clinical director for cancer, NHS England